Innovid Statistics
Total Valuation
Innovid has a market cap or net worth of $245.50 million. The enterprise value is $225.49 million.
| Market Cap | 245.50M |
| Enterprise Value | 225.49M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Innovid has 144.41 million shares outstanding. The number of shares has increased by 4.68% in one year.
| Shares Outstanding | 144.41M |
| Shares Change (YoY) | +4.68% |
| Shares Change (QoQ) | +1.10% |
| Owned by Insiders (%) | 13.68% |
| Owned by Institutions (%) | 54.47% |
| Float | 93.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.68 |
| Forward PS | n/a |
| PB Ratio | 1.27 |
| P/FCF Ratio | 34.83 |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 31.99 |
Financial Position
The company has a current ratio of 3.23, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.23 |
| Quick Ratio | 2.98 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.64 |
| Interest Coverage | 28.21 |
Financial Efficiency
Return on equity (ROE) is -15.30% and return on invested capital (ROIC) is -13.55%.
| Return on Equity (ROE) | -15.30% |
| Return on Assets (ROA) | -12.10% |
| Return on Capital (ROIC) | -13.55% |
| Revenue Per Employee | $313,594 |
| Profits Per Employee | -$63,481 |
| Employee Count | 466 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Innovid has paid $2.73 million in taxes.
| Income Tax | 2.73M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +46.55% in the last 52 weeks. The beta is 3.21, so Innovid's price volatility has been higher than the market average.
| Beta (5Y) | 3.21 |
| 52-Week Price Change | +46.55% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 34.29 |
| Average Volume (20 Days) | 1,095,775 |
Short Selling Information
The latest short interest is 435,652, so 0.30% of the outstanding shares have been sold short.
| Short Interest | 435,652 |
| Short Previous Month | 392,959 |
| Short % of Shares Out | 0.30% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, Innovid had revenue of $146.14 million and -$29.58 million in losses. Loss per share was -$0.21.
| Revenue | 146.14M |
| Gross Profit | 111.86M |
| Operating Income | -27.84M |
| Pretax Income | -26.86M |
| Net Income | -29.58M |
| EBITDA | -14.25M |
| EBIT | -27.84M |
| Loss Per Share | -$0.21 |
Balance Sheet
The company has $31.57 million in cash and $11.56 million in debt, giving a net cash position of $20.02 million or $0.14 per share.
| Cash & Cash Equivalents | 31.57M |
| Total Debt | 11.56M |
| Net Cash | 20.02M |
| Net Cash Per Share | $0.14 |
| Equity (Book Value) | 193.92M |
| Book Value Per Share | 1.34 |
| Working Capital | 54.87M |
Cash Flow
In the last 12 months, operating cash flow was $16.72 million and capital expenditures -$9.68 million, giving a free cash flow of $7.05 million.
| Operating Cash Flow | 16.72M |
| Capital Expenditures | -9.68M |
| Free Cash Flow | 7.05M |
| FCF Per Share | $0.05 |
Margins
Gross margin is 76.55%, with operating and profit margins of -19.05% and -20.24%.
| Gross Margin | 76.55% |
| Operating Margin | -19.05% |
| Pretax Margin | -18.38% |
| Profit Margin | -20.24% |
| EBITDA Margin | -9.75% |
| EBIT Margin | -19.05% |
| FCF Margin | 4.82% |
Dividends & Yields
Innovid does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.68% |
| Shareholder Yield | -4.68% |
| Earnings Yield | -12.05% |
| FCF Yield | 2.87% |
Analyst Forecast
The average price target for Innovid is $2.70, which is 58.82% higher than the current price. The consensus rating is "Buy".
| Price Target | $2.70 |
| Price Target Difference | 58.82% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Innovid has an Altman Z-Score of 2.77 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.77 |
| Piotroski F-Score | 5 |